This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2005 Oct;10(9):760-1.

doi: 10.1634/theoncologist.10-9-760.

Nimotuzumab: evidence of clinical benefit without rash

David G P Allan

PMID: 16249358
DOI: 10.1634/theoncologist.10-9-760

Free article

Comment

Nimotuzumab: evidence of clinical benefit without rash

David G P Allan. Oncologist. 2005 Oct.

Free article

. 2005 Oct;10(9):760-1.

doi: 10.1634/theoncologist.10-9-760.

Author

David G P Allan

PMID: 16249358
DOI: 10.1634/theoncologist.10-9-760

No abstract available

PubMed Disclaimer

Comment on

HER1/EGFR inhibitor-associated rash: future directions for management and investigation outcomes from the HER1/EGFR inhibitor rash management forum.
Pérez-Soler R, Delord JP, Halpern A, Kelly K, Krueger J, Sureda BM, von Pawel J, Temel J, Siena S, Soulières D, Saltz L, Leyden J. Pérez-Soler R, et al. Oncologist. 2005 May;10(5):345-56. doi: 10.1634/theoncologist.10-5-345. Oncologist. 2005. PMID: 15851793 Review.

Similar articles

Is cetuximab-induced rash conclusion really a remnant of the skin erythema dose?
Oskan F, Belka C, Manapov F. Oskan F, et al. Int J Radiat Oncol Biol Phys. 2013 Nov 1;87(3):462-3. doi: 10.1016/j.ijrobp.2013.06.2058. Int J Radiat Oncol Biol Phys. 2013. PMID: 24074919 No abstract available.
Kinase inhibitor-induced pustules.
Laffitte E, Saurat JH. Laffitte E, et al. Dermatology. 2005;211(4):305-6. doi: 10.1159/000088496. Dermatology. 2005. PMID: 16286735 No abstract available.
Trichomegaly of the eyelashes during therapy with epidermal growth factor receptor inhibitors: report of 3 cases.
Fabbrocini G, Panariello L, Cacciapuoti S, Bianca D, Ayala F. Fabbrocini G, et al. Dermatitis. 2012 Sep-Oct;23(5):237-8. doi: 10.1097/DER.0b013e31826e45d7. Dermatitis. 2012. PMID: 23010833
Nursing management of epidermal growth factor receptor inhibitor-induced toxicities.
Dunsford J. Dunsford J. Clin J Oncol Nurs. 2008 Jun;12(3):405-7. doi: 10.1188/08.CJON.405-407. Clin J Oncol Nurs. 2008. PMID: 18515238 Review. No abstract available.
Epidermal growth factor receptor inhibitor-associated cutaneous toxicities: an evolving paradigm in clinical management.
Lynch TJ Jr, Kim ES, Eaby B, Garey J, West DP, Lacouture ME. Lynch TJ Jr, et al. Oncologist. 2007 May;12(5):610-21. doi: 10.1634/theoncologist.12-5-610. Oncologist. 2007. PMID: 17522250 Review.

See all similar articles

Cited by

Near infrared fluorescence imaging of EGFR expression in vivo using IRDye800CW-nimotuzumab.
Bernhard W, El-Sayed A, Barreto K, Gonzalez C, Hill W, Parada AC, Fonge H, Geyer CR. Bernhard W, et al. Oncotarget. 2017 Dec 21;9(5):6213-6227. doi: 10.18632/oncotarget.23557. eCollection 2018 Jan 19. Oncotarget. 2017. PMID: 29464066 Free PMC article.
Control of advanced cancer: the road to chronicity.
Lage A, Crombet T. Lage A, et al. Int J Environ Res Public Health. 2011 Mar;8(3):683-97. doi: 10.3390/ijerph8030683. Epub 2011 Mar 1. Int J Environ Res Public Health. 2011. PMID: 21556173 Free PMC article. Review.
Immune biomarkers of anti-EGFR monoclonal antibody therapy.
Trivedi S, Concha-Benavente F, Srivastava RM, Jie HB, Gibson SP, Schmitt NC, Ferris RL. Trivedi S, et al. Ann Oncol. 2015 Jan;26(1):40-47. doi: 10.1093/annonc/mdu156. Epub 2014 Jul 4. Ann Oncol. 2015. PMID: 24997207 Free PMC article. Review.
Antibody h-R3-dendrimer mediated siRNA has excellent endosomal escape and tumor targeted delivery ability, and represents efficient siPLK1 silencing and inhibition of cell proliferation, migration and invasion.
Li J, Liu J, Li S, Hao Y, Chen L, Zhang X. Li J, et al. Oncotarget. 2016 Mar 22;7(12):13782-96. doi: 10.18632/oncotarget.7368. Oncotarget. 2016. PMID: 26883109 Free PMC article.
Prognostic and predictive roles of cancer stem cell markers in head and neck squamous cell carcinoma patients receiving chemoradiotherapy with or without nimotuzumab.
Patel U, Kannan S, Rane SU, Mittal N, Gera P, Patil A, Manna S, Shejwal V, Noronha V, Joshi A, Patil VM, Prabhash K, Mahimkar MB. Patel U, et al. Br J Cancer. 2022 Jun;126(10):1439-1449. doi: 10.1038/s41416-022-01730-9. Epub 2022 Feb 9. Br J Cancer. 2022. PMID: 35140342 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information